These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3418647)

  • 21. Duration of Raynaud's phenomenon is negatively correlated with serum levels of interleukin 10 (IL-10), soluble receptor of interleukin 2 (sIL2R), and sFas in systemic sclerosis patients.
    Dziankowska-Bartkowiak B; Zalewska A; Sysa-Jedrzejowska A
    Med Sci Monit; 2004 May; 10(5):CR202-8. PubMed ID: 15114270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmented interleukin-6 secretion in collagen-stimulated peripheral blood mononuclear cells from patients with systemic sclerosis.
    Gurram M; Pahwa S; Frieri M
    Ann Allergy; 1994 Dec; 73(6):493-6. PubMed ID: 7998663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migratory interaction of amphibian epidermal cells with components of the basement membrane.
    Donaldson DJ; Mahan JT; Tsilibary EC; McCarthy JB; Dixit SN; Chung AE
    J Cell Physiol; 1994 Jan; 158(1):79-86. PubMed ID: 8263031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basement membrane components (7S collagen, laminin P1) are increased in sera of diabetics and activate platelets in vitro.
    Högemann B; Balleisen L; Rauterberg J; Voss B; Gerlach U
    Haemostasis; 1986; 16(6):428-32. PubMed ID: 3583098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
    Neudecker BA; Stern R; Connolly MK
    Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis.
    Mok MY; Cheung BM; Lo Y; Leung RY; Wong WS; Lau CS
    J Rheumatol; 2007 Nov; 34(11):2224-9. PubMed ID: 17937467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis.
    Bahr MJ; Böker KH; Horn W; Günzler V; Manns MP
    Hepatogastroenterology; 1997; 44(16):1200-5. PubMed ID: 9261625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-affinity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV.
    Brittingham R; Uitto J; Fertala A
    Biochem Biophys Res Commun; 2006 May; 343(3):692-9. PubMed ID: 16563355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.
    Pancera P; Sansone S; Presciuttini B; Montagna L; Cerù S; Lunardi C; Lechi A
    Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenon.
    Gabrielli A; Montroni M; Rupoli S; Caniglia ML; DeLustro F; Danieli G
    Arthritis Rheum; 1988 Nov; 31(11):1432-6. PubMed ID: 3190785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cellular immune phenomenon in scleroderma].
    Fritz J; Sandhofer M
    Dermatologica; 1977; 154(3):129-37. PubMed ID: 852625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiological effects of endothelial cytotoxic activity derived from sera of patients with progressive systemic sclerosis.
    Drenk F; Deicher HR
    J Rheumatol; 1988 Mar; 15(3):468-74. PubMed ID: 3379623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum collagen IV and laminin levels in preeclampsia.
    Furuhashi N; Kimura H; Nagae H; Yajima A; Kimura C; Saito T
    Gynecol Obstet Invest; 1994; 37(4):250-3. PubMed ID: 8050729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration.
    Black CM; McWhirter A; Harrison NK; Kirk JM; Laurent GJ
    Br J Rheumatol; 1989 Apr; 28(2):98-103. PubMed ID: 2706431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum concentration of type IV collagen in urological cancer--comparison with serum concentration of laminin].
    Isobe H; Iwata S; Fujime M; Kitagawa R
    Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):457-62. PubMed ID: 8515631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration of serum laminin and type IV collagen in liver diseases assayed by a sandwich enzyme-immunoassay using monoclonal antibodies.
    Yokoya Y; Iwata K; Muragaki Y; Shiota C; Morimoto Y; Inoue M; Itoh H; Nishioka S; Ooshima A
    Clin Chim Acta; 1992 Sep; 210(1-2):109-18. PubMed ID: 1330375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma.
    Krieg T; Langer I; Gerstmeier H; Keller J; Mensing H; Goerz G; Timpl R
    J Invest Dermatol; 1986 Dec; 87(6):788-91. PubMed ID: 3782862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of an LtB4-protein complex as evidence of endothelial cell cytotoxic activity (ECA) in progressive systemic sclerosis (PSS).
    Deicher HR; Drenk F; Hoffman G
    Z Rheumatol; 1987; 46(4):196-7. PubMed ID: 2823504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum laminin P1 fragment concentration in renal diseases.
    Horikoshi S; Koide H
    Clin Chim Acta; 1991 Feb; 196(2-3):185-91. PubMed ID: 2029784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.